We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01859117
Recruitment Status : Completed
First Posted : May 21, 2013
Last Update Posted : March 1, 2018
Information provided by (Responsible Party):
Celularity Incorporated

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2016
  Study Completion Date : October 2016